Novel neuroprotective, neuritogenic and anti-amyloidogenic properties of 2,4-dinitrophenol: The gentle face of Janus

被引:42
作者
De Felice, Fernanda G. [1 ]
Ferreira, Sergio T.
机构
[1] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Bioquim & Biofis Celular, BR-21944590 Rio De Janeiro, Brazil
[2] Northwestern Univ, Dept Physiol & Neurobiol, Evanston, IL 60208 USA
关键词
2,4-dinitrophenol; low concentrations; neuroprotection; amyloid-beta peptide;
D O I
10.1080/15216540600702198
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Roman mythology, Janus was the god of gates, doors, beginnings and endings. He was usually depicted with two faces looking in opposite directions. Janus was frequently used to symbolize change and transitions, such as the progression from past to future or from one viewpoint to another. 2,4-dinitrophenol (DNP) and other nitrophenols have long been known to be toxic at high concentrations (the `bad' face of DNP), an effect that appears essentially related to interference with cellular energy metabolism due to uncoupling of mitochondrial oxidative phosphorylation. Five years ago, however, we published the first report showing that low concentrations of DNP protect neurons against the toxicity of the amyloid-beta peptide [De Felice et al. (2001) FASEB J. 15: 1297-1299]. Since then, other studies have provided evidence of beneficial actions of DNP (at low concentrations), including neuroprotection against different types of insult, blockade of amyloid aggregation, stimulation of neurite outgrowth and neuronal differentiation, and even extension of lifespan in certain organisms. Some of these effects appear to be due to mild mitochondrial uncoupling and prevention of cellular oxidative stress, whereas other actions are related to activation of additional intracellular signaling pathways. Thus, a novel and `gentle' face of DNP is emerging from such studies. In this review, we discuss both toxic and beneficial actions of DNP. The evidence available so far suggests that DNP and other compounds with similar biological activities may be of significant interest to the development of novel therapeutic approaches for neurodegenerative diseases and other neurological disorders.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 44 条
[1]   Role of tau protein in both physiological and pathological conditions [J].
Avila, J ;
Lucas, JJ ;
Pérez, M ;
Hernández, F .
PHYSIOLOGICAL REVIEWS, 2004, 84 (02) :361-384
[2]   Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae [J].
Barros, MH ;
Bandy, B ;
Tahara, EB ;
Kowaltowski, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (48) :49883-49888
[3]   The Neuronal Cytoskeleton as a Potential Therapeutical Target in Neurodegenerative Diseases and Schizophrenia [J].
Benitez-King, G. ;
Ramirez-Rodriguez, G. ;
Ortiz, L. ;
Meza, I .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2004, 3 (06) :515-533
[4]   EXPERIMENTAL DINITROPHENOL CATARACT [J].
BETTMAN, JW .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1946, 29 (11) :1388-1395
[5]   Calorie restriction, SIRT1 and metabolism: Understanding longevity [J].
Bordone, L ;
Guarente, L .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (04) :298-305
[6]   Uncoupling to survive? The role of mitochondrial inefficiency in ageing [J].
Brand, MD .
EXPERIMENTAL GERONTOLOGY, 2000, 35 (6-7) :811-820
[7]   Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate [J].
Cai, D ;
Qiu, J ;
Cao, ZX ;
McAtee, M ;
Bregman, BS ;
Filbin, MT .
JOURNAL OF NEUROSCIENCE, 2001, 21 (13) :4731-4739
[8]   4′-iodo-4′-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species:: screening for TTR fibril disrupters [J].
Cardoso, I ;
Merlini, G ;
Saraiva, MJ .
FASEB JOURNAL, 2003, 17 (08) :803-809
[9]   Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms [J].
Czech, C ;
Tremp, G ;
Pradier, L .
PROGRESS IN NEUROBIOLOGY, 2000, 60 (04) :363-384
[10]   Targeting the neurotoxic species in Alzheimer's disease:: inhibitors of Aβ oligomerization [J].
De Felice, FG ;
Vieira, MNN ;
Saraiva, LM ;
Figueroa-Villar, JD ;
Garcia-Abreu, J ;
Liu, R ;
Chang, L ;
Klein, WL ;
Ferreira, ST .
FASEB JOURNAL, 2004, 18 (12) :1366-1372